BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Treatment
159 results:

  • 1. Principles in the Management of Glioblastoma.
    Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Intranasal delivery of herbal medicine for disease treatment: A systematic review.
    Tran KN; Kwon JH; Kim MK; Nguyen NPK; Yang IJ
    Phytomedicine; 2024 May; 127():155484. PubMed ID: 38442431
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
    Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
    Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
    Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
    Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature.
    Zhu Z; Liu Y; Xu H; Ning H; Xia Y; Shen L
    J Cardiothorac Surg; 2023 Aug; 18(1):254. PubMed ID: 37653509
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas.
    Medina EJ; Zohdy YM; Porto E; Revuelta Barbero JM; Bray D; Maldonado J; Rodas A; Mayol M; Morales B; Neill S; Read W; Pradilla G; Ioachimescu A; Garzon-Muvdi T
    Front Endocrinol (Lausanne); 2023; 14():1195792. PubMed ID: 37529607
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.
    Jiang Z; Ju Y; Ali A; Chung PED; Skowron P; Wang DY; Shrestha M; Li H; Liu JC; Vorobieva I; Ghanbari-Azarnier R; Mwewa E; Koritzinsky M; Ben-David Y; Woodgett JR; Perou CM; Dupuy A; Bader GD; Egan SE; Taylor MD; Zacksenhaus E
    Nat Commun; 2023 Jul; 14(1):4313. PubMed ID: 37463901
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Benign and Malignant Tumors of the Pineal Region.
    Upadhyayula PS; Neira JA; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():153-173. PubMed ID: 37452938
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma Cells via CDK4/6 Inhibition.
    Wang Y; Li Y; Liu D; Zheng D; Li X; Li C; Huang C; Wang Y; Wang X; Li Q; Xu J
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446710
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era.
    Xie X; Qiu G; Chen Z; Liu T; Yang Y; You Z; Zeng C; Lin X; Xie Z; Qin Y; Wang Y; Ma X; Zhou C; Liu M
    Clin Transl Oncol; 2024 Feb; 26(2):434-445. PubMed ID: 37436674
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer.
    Lee K; Lee J; Choi J; Sim SH; Kim JE; Kim MH; Park YH; Kim JH; Koh SJ; Park KH; Kang MJ; Ahn MS; Lee KE; Kim HJ; Ahn HK; Kim HJ; Park KU; Park IH
    Sci Rep; 2023 Jun; 13(1):9928. PubMed ID: 37336919
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inhibition of protein arginine deiminase II suppresses retinoblastoma in orthotopic transplantation in mice.
    Kim S; Song YK; Cho CS; Kim HJ; Fang S; Jo DH; Kim H
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37326108
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.
    Lazzarini E; Silvestris DA; Benvenuto G; Osti D; Fattore L; Paterra R; Finocchiaro G; Malatesta P; Daga A; Gallotti AL; Galli R; Pelicci G; Tesei A; Bedeschi M; Pallini R; Pasqualini L; Romualdi C; Gallo A; Ricci-Vitiani L; Indraccolo S
    J Neurooncol; 2023 May; 163(1):47-59. PubMed ID: 37140883
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Integrative Analysis of a Large Real-World Cohort of Small Cell Lung cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation.
    Sivakumar S; Moore JA; Montesion M; Sharaf R; Lin DI; Colón CI; Fleishmann Z; Ebot EM; Newberg JY; Mills JM; Hegde PS; Pan Q; Dowlati A; Frampton GM; Sage J; Lovly CM
    Cancer Discov; 2023 Jul; 13(7):1572-1591. PubMed ID: 37062002
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
    Chamorro DF; Cardona AF; Rodríguez J; Ruiz-Patiño A; Arrieta O; Moreno-Pérez DA; Rojas L; Zatarain-Barrón ZL; Ardila DV; Viola L; Recondo G; Blaquier JB; Martín C; Raez L; Samtani S; Ordóñez-Reyes C; Garcia-Robledo JE; Corrales L; Sotelo C; Ricaurte L; Cuello M; Mejía S; Jaller E; Vargas C; Carranza H; Otero J; Archila P; Bermudez M; Gamez T; Russo A; Malapelle U; de Miguel Perez D; de Lima VCC; Freitas H; Saldahna E; Rolfo C; Rosell R;
    Target Oncol; 2023 May; 18(3):425-440. PubMed ID: 37017806
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case series.
    Lavrador JP; Reisz Z; Sibtain N; Rajwani K; Baig Mirza A; Vergani F; Gullan R; Bhangoo R; Ashkan K; Bleil C; Zebian B; Clark B; Laxton R; King A; Bodi I; Al-Saraj S
    Acta Neurochir (Wien); 2023 Jun; 165(6):1615-1633. PubMed ID: 36929449
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Translational Orthotopic Models of Glioblastoma Multiforme.
    El Meskini R; Atkinson D; Weaver Ohler Z
    J Vis Exp; 2023 Feb; (192):. PubMed ID: 36876943
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma treatment In Vitro and In Vivo.
    Jonchere B; Williams J; Zindy F; Liu J; Robinson S; Farmer DM; Min J; Yang L; Stripay JL; Wang Y; Freeman BB; Yu J; Shelat AA; Rankovic Z; Roussel MF
    Mol Cancer Ther; 2023 Jan; 22(1):37-51. PubMed ID: 36318650
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Predictive Model to Guide brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung cancer: Impact on Real-World Outcomes.
    Wu J; Ding V; Luo S; Choi E; Hellyer J; Myall N; Henry S; Wood D; Stehr H; Ji H; Nagpal S; Hayden Gephart M; Wakelee H; Neal J; Han SS
    JCO Precis Oncol; 2022 Oct; 6():e2200220. PubMed ID: 36201713
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.